Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

2 evidence items · page 1 / 1

7.5 %Compared to mean coverage in infants, static coverage at 12 months was exaggerated by 7–8% for third doses of oral polio, pentavalent (Penta3) and pneumococcal conjugate vaccines.

Kenyapentavalent · pneumococcal · poliomyéliteobserved 2010 to 2017published 2018Vaccineeurope_pmcdocument of 5 observations

7.5 %Static coverage at 12 months was exaggerated by 7–8% for third doses of oral polio, pentavalent (Penta3) and pneumococcal conjugate vaccines compared to mean coverage in infants.

Kenyapentavalent · pneumococcal · poliomyélitepublished 2018Coverage and timeliness of vaccination and the validity of routine estimates: Insights froeurope_pmcdocument of 4 observationsDOI 10.1101/427773

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.